teleo-codex/inbox/archive/.extraction-debug/2025-01-01-jmir-digital-engagement-glp1-weight-loss-outcomes.json
Teleo Agents 07c19cc286 extract: 2025-01-01-jmir-digital-engagement-glp1-weight-loss-outcomes
Pentagon-Agent: Epimetheus <968B2991-E2DF-4006-B962-F5B0A0CC8ACA>
2026-03-16 21:58:55 +00:00

26 lines
No EOL
1.3 KiB
JSON

{
"rejected_claims": [
{
"filename": "digital-behavioral-support-combined-with-glp1-achieves-44-percent-greater-weight-loss-than-medication-alone-while-halving-drug-requirements.md",
"issues": [
"missing_attribution_extractor"
]
}
],
"validation_stats": {
"total": 1,
"kept": 0,
"fixed": 3,
"rejected": 1,
"fixes_applied": [
"digital-behavioral-support-combined-with-glp1-achieves-44-percent-greater-weight-loss-than-medication-alone-while-halving-drug-requirements.md:set_created:2026-03-16",
"digital-behavioral-support-combined-with-glp1-achieves-44-percent-greater-weight-loss-than-medication-alone-while-halving-drug-requirements.md:stripped_wiki_link:glp-1-persistence-drops-to-15-percent-at-two-years-for-non-d",
"digital-behavioral-support-combined-with-glp1-achieves-44-percent-greater-weight-loss-than-medication-alone-while-halving-drug-requirements.md:stripped_wiki_link:GLP-1 receptor agonists are the largest therapeutic category"
],
"rejections": [
"digital-behavioral-support-combined-with-glp1-achieves-44-percent-greater-weight-loss-than-medication-alone-while-halving-drug-requirements.md:missing_attribution_extractor"
]
},
"model": "anthropic/claude-sonnet-4.5",
"date": "2026-03-16"
}